REFERENCES
1. Liberale L, Kraler S, Camici GG, Lüscher TF. Ageing and longevity genes in cardiovascular diseases. Basic Clin Pharmacol Toxicol 2020;127:120-31.
2. Sokolov SS, Severin FF. Manipulating cellular energetics to slow aging of tissues and organs. Biochemistry (Mosc) 2020;85:651-9.
3. Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 2020;21:183-203.
4. Statzer C, Meng J, Venz R, et al. ATF-4 and hydrogen sulfide signalling mediate longevity in response to inhibition of translation or mTORC1. Nat Commun 2022;13:967.
5. Longchamp A, Mirabella T, Arduini A, et al. Amino acid restriction triggers angiogenesis via GCN2/ATF4 regulation of VEGF and H2S production. Cell 2018;173:117-129.e14.
6. LaPenna KB, Polhemus DJ, Doiron JE, et al. Hydrogen sulfide as a potential therapy for heart failure-past, present, and future. Antioxidants (Basel) 2021;10:485.
7. Testai L, Citi V, Martelli A, Brogi S, Calderone V. Role of hydrogen sulfide in cardiovascular ageing. Pharmacol Res 2020;160:105125.
8. Bithi N, Link C, Henderson YO, et al. Dietary restriction transforms the mammalian protein persulfidome in a tissue-specific and cystathionine γ-lyase-dependent manner. Nat Commun 2021;12:1745.
9. Vanhoutte D, Schips TG, Vo A, et al. Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nat Commun 2021;12:3928.
